Open AccessImpact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing
Author(s) -
J. Harward,
Valerie B. Clinard,
Michael R. Jiroutek,
B. Lingerfeldt,
Andrew J. Muzyk
Publication year - 2015
Publication title -
the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.14m01728
Subject(s) - zolpidem , drug , dosing , food and drug administration , pharmacology , medicine , drug administration , insomnia
Zolpidem is a sedative-hypnotic widely prescribed in the United States. Recently, the US Food and Drug Administration (FDA) issued a drug safety communication regarding its dosing in women.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom